scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1091206647 |
P356 | DOI | 10.1186/S12881-017-0448-X |
P932 | PMC publication ID | 5559773 |
P698 | PubMed publication ID | 28814288 |
P50 | author | Mohammed N Nimir | Q57089776 |
Hisham Altayb | Q57903494 | ||
P2093 | author name string | Mohamed D Dafaalla | |
Musaab M Alfaki | |||
Muzamil Mahdi Abdel Hamid | |||
Mona Ellaithi | |||
Mohamed Adel Taha | |||
Abdelmohaymin A Abdalla | |||
Alsmawal A Elimam | |||
Mohamed A Abdelrahim | |||
Mohamed Ahmed Salih Hassan | |||
Mohamed El-Fatih Moly Eldeen | |||
Mohamed Elmogtba Mouaweia Mohamed Aabdein | |||
Musab I Mohammed | |||
P2860 | cites work | Isolation of genomic DNA from human whole blood | Q78721624 |
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland | Q80243226 | ||
Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history | Q82151956 | ||
The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51 | Q24323065 | ||
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 | ||
Meta-analysis of BRCA1 and BRCA2 penetrance | Q24654786 | ||
I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure | Q24812223 | ||
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers | Q27851474 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
SIFT: Predicting amino acid changes that affect protein function | Q29547211 | ||
Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
BRCA2 is required for homology-directed repair of chromosomal breaks | Q29618799 | ||
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces | Q30396003 | ||
BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history | Q33330316 | ||
Breast cancer in Sub-Saharan Africa: opportunities for prevention | Q33622597 | ||
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis | Q33845209 | ||
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes | Q33942332 | ||
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations | Q33946674 | ||
The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population | Q33991747 | ||
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers | Q34044197 | ||
Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer | Q34335495 | ||
Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms | Q35081603 | ||
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients | Q35527158 | ||
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer | Q35957703 | ||
Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients | Q36003635 | ||
Screening of BRCA1/2 Mutations Using Direct Sequencing in Indonesian Familial Breast Cancer Cases | Q36028711 | ||
Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer | Q36135879 | ||
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer | Q36286597 | ||
BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families. | Q36471022 | ||
Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer | Q36656262 | ||
A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer | Q36770256 | ||
Genetic susceptibility for breast cancer: how many more genes to be found? | Q36820486 | ||
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing | Q37176931 | ||
Hereditary breast cancer: new genetic developments, new therapeutic avenues | Q37199029 | ||
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families | Q37304615 | ||
BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families | Q37323349 | ||
Implementation of a breast cancer genetic service in South Africa - lessons learned. | Q38124050 | ||
Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient? | Q38750393 | ||
Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients | Q38904251 | ||
Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer | Q39009508 | ||
A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancer | Q39040163 | ||
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families | Q39395789 | ||
Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia. | Q39395809 | ||
High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families | Q39395816 | ||
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants | Q39514959 | ||
Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. | Q39534663 | ||
Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer | Q39635066 | ||
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds | Q41226231 | ||
Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study | Q41409355 | ||
Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden | Q41835115 | ||
Predicting functional effect of human missense mutations using PolyPhen-2. | Q42406410 | ||
Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients | Q43073348 | ||
Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer | Q43844860 | ||
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients | Q44634590 | ||
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. | Q44946113 | ||
BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors | Q46490970 | ||
Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry | Q47445017 | ||
Cancer variation associated with the position of the mutation in the BRCA2 gene | Q47636266 | ||
A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa | Q48654661 | ||
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer | Q50690518 | ||
MutationTaster2: mutation prediction for the deep-sequencing age. | Q52877992 | ||
Internal repeats in the BRCA2 protein sequence | Q53173241 | ||
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer | Q57693923 | ||
Phenotypic effects of heterozygosity for a BRCA2 mutation | Q63383838 | ||
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo | Q64388833 | ||
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene | Q71955901 | ||
Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer | Q73096316 | ||
P433 | issue | 1 | |
P921 | main subject | heterozygosity | Q124059385 |
P304 | page(s) | 85 | |
P577 | publication date | 2017-08-16 | |
P1433 | published in | BMC Medical Genetics | Q15759918 |
P1476 | title | Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer | |
P478 | volume | 18 |
Q64039257 | BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry | cites work | P2860 |
Search more.